|
全国免费电话：400-668-6834 -- 仅限中国地区 -- |
在线订购：QQ: 4006686834 电话订购：021-68591985 邮件订购：info@selleck.cn 我们也提供销售人员上门服务 |
技术支持电话：400-168-6834 我们将于一个工作日与您联系 |
Anti-mouse IFNγ (XMG1.2)-InVivo
目录号：A2152 批次号: A215205
克隆号：XMG1.2
Anti-mouse IFNγ (XMG1.2)-InVivo与小鼠 IFNγ（干扰素γ）发生反应，IFNγ 是一种 20 kDa 可溶性多效性细胞因子，也是 II 型干扰素的唯一成员。
抗体信息
| 克隆号 | XMG1.2 |
|---|---|
| 配制 | PBS, pH 7.0 Contains no stabilizers or preservatives |
| 推荐同型对照 | Rat IgG1, κ |
| 应用 | Anti-mouse IFNγ (XMG1.2)-InVivo |
| 来源 | CHO |
| 小鼠病原体检测 | all targets tested yielded Negative Results: Theiler’s Murine Encephalomyelitis Virus, Ectromelia (Mousepox) Virus, Hantavirus, Polyomavirus, Sendai Virus, Mycoplasma pulmonis, Pneumonia Virus of Mice, K Virus, Mouse Parvovirus, Mouse Hepatitis Virus, Mouse Norovirus, Mouse Minute Virus, Mouse Cytomegalovirus, Mouse Adenovirus, Lactate Dehydrogenase-Elevating Virus, Reovirus Panel, Lymphocytic Choriomeningitis Virus, Mouse Rotavirus. |
| 储存条件 (自收到货起) |
Store the undiluted solution at 4°C in the dark to avoid freeze-thaw cycles |
| 除菌 | 0.2 μM filtered |
| 纯度 | 99% |
| 蛋白浓度 | 6.97 mg/ml |
| 内毒素 | ＜1EU/mg |
Anti-mouse IFNγ (XMG1.2)-InVivo在文献中得到引用
| Low-dose radiotherapy synergizes with PD-1 blockade to achieve durable survival in advanced NSCLC through antitumor neutrophil programming [ Signal Transduction and Targeted Therapy, May 7, 2026, 11(1):170] | PubMed: 42091852 |
| DOCK2 protects against bacterial sepsis by constraining T helper 1 response [ Frontiers in Immunology, May 29, 2025, 16:1527934] | PubMed: 40510337 |
| Clostridium scindens attenuates acute kidney injury by producing indole-3-acetic acid [ npj Biofilms and Microbiomes, December 15, 2025, 12(1):16] | PubMed: 41397986 |
| Clostridium scindens attenuates acute kidney injury by producing indole-3-acetic acid [ npj Biofilms and Microbiomes, 2025, 12(1)] | PubMed: 41397986 |
| DOCK2 protects against bacterial sepsis by constraining T helper 1 response [ Front Immunol, 2025, 16:1527934] | PubMed: 40510337 |
| DOCK2 protects against bacterial sepsis by constraining T helper 1 response [ Frontiers in Immunology, 2025, 1527934] | PubMed: 40510337 |
| A pan-allelic human SIRPα-blocking antibody, ES004-B5, promotes tumor killing by enhancing macrophage phagocytosis and subsequently inducing an effective T-cell response [ Antibody Therapeutics, 2024, 266-280] | PubMed: 39257438 |
| A pan-allelic human SIRPα-blocking antibody, ES004-B5, promotes tumor killing by enhancing macrophage phagocytosis and subsequently inducing an effective T-cell response [ Antib Ther, 2024, 7(3):266-280] | PubMed: 39257438 |
禁止用于人体及治疗！